Brentuximab vedotin for relapsed or refractory Hodgkin’s lymphoma

Title
Brentuximab vedotin for relapsed or refractory Hodgkin’s lymphoma
Authors
Keywords
-
Journal
Drug Design Development and Therapy
Volume -, Issue -, Pages 1729
Publisher
Dove Medical Press Ltd.
Online
2015-03-24
DOI
10.2147/dddt.s82007

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search